LNAI — Lunai Bioworks Share News
0.000.00%
Last trade - 00:00- $1.48m
- $0.76m
- $0.05m
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:06 PM
Brief: Lunai Bioworks Expands Parkinson's Platform Through Exclusive Tanaist Agreement
Brief: Lunai Bioworks Signs Agreement With Brainstorm Therapeutics
Brief: Lunai Bioworks - Regains Nasdaq Compliance With Minimum $1 Bid Price Rule - SEC Filing
Brief: Lunai Bioworks Federal Judge Grants Lunai Bioworks Expedited Discovery To Identify "Naked" Short Sellers
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Lunai Bioworks, Inc. Announces Reverse Stock Split
Brief: Lunai Bioworks Inc - Approves Reverse Stock Split At Ratio Of 1-For-3 To 1-For-30 - SEC Filing
NASDAQ RESUMED AT 09:42 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:37 AM
Brief: Lunai Bioworks Executes $20M Strategic Transaction At Fixed $1.50 Conversion, Acquiring Bbb Delivery Platform For Cns Alzheimer's Therapies With Broad Cns Delivery Applications
Brief: Lunai Bioworks Implements Temporary Furlough Of Employees In US And Canada- SEC Filing
Brief: Lunai Bioworks (Nasdaq Lnai) Launches Ai Oncology Pilot
Brief: Lunai Bioworks Identifies Three Parkinson's Disease Subtypes
Brief: Lunai Bioworks - Enters Sales Agreement With Dawson James Securities - SEC Filing
Brief: Lunai Bioworks Inc - Gedi Cube B.V. Declared Bankrupt By Court Of Amsterdam - SEC Filing
Brief: Renovaro - Maurice Van Tilburg Resigns As Chairman Of Renovaro - SEC Filing
Brief: Renovaro Inc - Enters Exchange Agreement With Accredited Investors